18F-FAPI PET/CT and MRI in Gastric Cancer
ConditionGastric Cancer
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20-80
SponsorFirst Affiliated Hospital of Zhejiang University
About this trial
The purpose of this study was to evaluate the diagnostic efficacy and prognostic value of 18F-FAPI PET/CT combined with multiparameter MRI in gastric cancer.
Eligibility criteria
Qualifiers
Patients suspected or diagnosed with gastric cancer
18F-FAPI PET/CT has been performed
Gastric MRI with both non-contrast and contrast-enhanced scans performed
Disqualifiers
Concurrent presence of other active malignant tumors or a history of other malignant tumors within the past 5 years;
Severe uncontrollable diseases or active infections;
Ineligible participants who cannot provide informed consent for the study;
Patients with suboptimal image quality in 18F-FAPI PET/CT
Trial design
Treatments tested in this trial
- patients with suspected or confirmed gastric cancer who have undergone 18F-FAPI PET/CT and MRI (non-contrast + contrast-enhanced scans)
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov